Atpin 1 % Injection 1 ML

Atpin 1 % Injection 1 ML should be used during pregnancy only when absolutely necessary. Atropine can cross the placenta and may cause an increased heart rate in the foetus. Although limited data suggests minimal risk, your doctor will determine if the benefits outweigh potential risks.

Atropine may pass into breast milk and can cause antimuscarinic effects in the nursing infant, such as dry mouth or restlessness. It may also reduce milk production. Use  Atpin 1 % Injection 1 ML with caution and only on the advice of your doctor.
 

Alcohol consumption may worsen the side effects such as dizziness and drowsiness. Avoid alcohol while receiving Atpin 1 % Injection 1 ML.
 

No specific dose adjustment is mentioned for liver impairment. However, caution is advised. Inform your doctor if you have any known liver issues before taking  Atpin 1 % Injection 1 ML.
 

There is limited information regarding dose adjustment in kidney disorders, but caution is advised in kidney impairment. Speak to your doctor before administration if you have kidney concerns.
 

Atpin 1 % Injection 1 ML may cause dizziness, blurred vision or confusion. Do not drive or operate heavy machinery until you are fully alert and your vision is clear.

Do not use Atpin 1 % Injection 1 ML if you are allergic to atropine or similar anticholinergic agents. Inform your doctor of any known allergies before starting treatment.
 

Children are more susceptible to the side effects of Atpin 1 % Injection 1 ML. Dosing should be done cautiously under medical supervision.
 

Elderly patients are more prone to side effects such as confusion, hallucinations, and agitation. Careful monitoring is advised, and the dose may need adjustment.